Outcomes of a two-year national rare disease gene discovery project

June 5, 2014, Children's Hospital of Eastern Ontario Research Institute

As part of the Finding of Rare Disease Genes (FORGE) research project, Canadian researchers have developed an expertise in understanding the underlying biology of rare childhood disorders. The first public commentary of this nationwide study is available today in the American Journal of Human Genetics.

"When we launched this project, we predicted we might explain, or solve, 50 disorders; we've almost tripled that goal," said Dr. Kym Boycott, lead investigator of FORGE and clinician scientist at the Children's Hospital of Eastern Ontario (CHEO). "This was a leadership opportunity for Canada. Our team's rare disease expertise is now sought on an international stage – and it started with FORGE."

264 rare disorders were submitted by geneticists from across Canada and selected for the FORGE study. With a 55% success rate, the research team has already solved 146 disorders, including identification of 67 novel genes that had never been associated with a rare disease before.

The pan-Canada research team studied a wide range of childhood genetic disorders including neurodegenerative conditions and those that affect multiple systems in the body. They noted common biological pathways that crossed multiple rare disorders. This means that certain pathways may make better targets than others for designing therapies to treat , according to Dr. Boycott.

The technology they used to conduct this research is called exome sequencing. It's a sophisticated, lab-based method of testing all genes at once vs. traditionally testing one gene at a time. Using this approach, the researchers were surprised by how many genes they identified that were already known to cause rare disease, but were missed in the same families using traditional testing.

"The rewarding part of this project for all involved has been the many lives we've impacted," said Chandree Beaulieu, project manager of FORGE and first author of the report. "Every result was reported back to the families who participated in the research. The information never stayed in a lab or database. This was highly motivating for the entire team."

Dr. Boycott explains that delivering an evidence-based diagnosis to families can influence disease management: by informing what progression of the rare disease might look like; adjusting treatment by adding or removing a particular therapy; and, being able to offer informed reproductive counselling.

The FORGE project has now rolled into an international research program called CARE for RARE, also led at CHEO. The team's objective is to continue the quest to identify more rare disease genes, but also to design and test therapies in the lab to treat specific rare diseases.

Explore further: New therapy against rare gene defects

More information: For more information about CARE for RARE, visit: care4rare.ca/

Related Stories

New therapy against rare gene defects

April 15, 2014
On 15th April is the 1st International Pompe Disease Day, a campaign to raise awareness of this rare but severe gene defect. Pompe Disease is only one of more than 40 metabolic disorders that mainly affect children under ...

Scientists discover gene behind rare disorders

October 9, 2012
Scientists at the Montreal Neurological Institute and Hospital – The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Cancer therapy may be too targeted

March 16, 2014
Researchers have identified two novel cancer genes that are associated with the development of a rare, highly aggressive, cancer of blood vessels. These genes may now act as markers for future treatments and explain why narrowly ...

The genetic basis for uncommon and often unidentified medical conditions

February 27, 2014
In accord with this week's 7th annual World Rare Disease Day, Arizonans and patients from throughout the nation and around the globe are benefitting from rare disease research conducted by the non-profit Translational Genomics ...

EU releases 144 mn euro for new rare disease research

February 28, 2013
The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.

Common disorders: It's not the genes themselves, but how they are controlled

December 20, 2013
Many rare disorders are caused by gene mutation, like sickle cell anemia. Yet until now the underlying genetic cause of more common conditions – for example, rheumatoid arthritis – has evaded scientists for years.

Recommended for you

Researchers identify gene responsible for mesenchymal stem cells' stem-ness'

January 22, 2018
Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering ...

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Can mice really mirror humans when it comes to cancer?

January 18, 2018
A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.